Dopamine supersensitivity following chronic anti-dopaminergic treatment
Dopamine supersensitivity following chronic anti-dopaminergic treatment
批准号:
355923-2008
负责人:
Samaha, AnneNoel
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-01-01 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The dopamine (DA) system is critical for normal, everyday behaviours including eating, procreation and movement, but abnormal DA function is linked to a number of psychiatric disorders including psychosis and drug addiction. The most widely-used animal model of DA hyperactivity involves repeated stimulation of the DA system via administration of DA agonists (e.g., amphetamine) and this model has helped researchers to better understand DA function under normal and abnormal conditions. However, chronic suppression of the DA system (for example, via blockade of DA D2/3 receptors) also induces a DA hyperactive state. This alternate model of DA supersensitivity is an ideal tool to further our understanding of the DA system and its function. However, little is known about the long-term behavioural consequences of chronic DA receptor blockade or about the neurobiological processes involved in the induction of DA supersensitivity under these conditions. The primary goal of the proposed research, therefore, is to use animal models to determine the effects of chronic DA D2/3 receptor blockade on DA-dependent behaviours and to explore potential underlying mechanisms. This will be achieved by treating rats with the DA D2/3 receptor antagonist haloperidol and measuring their behavioural response in commonly-used tests of DA function, including psychomotor sensitization, intravenous drug self-administration and operant responding for conditioned reward. Prior research suggests that increased activity within a specific population of neurons that express the neuropeptide enkephalin and form the striatopallidal pathway might be a common mechanism underlying the ability of either DA agonists or DA D2/3 receptor antagonists to induce a DA supersensitive state. Therefore, I will determine whether the effects of haloperidol treatment on the DA-dependent behaviour mentioned above involve increased activity within the enkephalin/striatopallidal pathway. As such, these results will increase our basic understanding of the functions subserved by the DA system and allow us to better predict outcome when DA function is abnormal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$0.91万
-
财政年份:2014
-
负责人:Samaha, AnneNoel
-
依托单位:
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.82万
-
财政年份:2012
-
负责人:Samaha, AnneNoel
-
依托单位:
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.82万
-
财政年份:2011
-
负责人:Samaha, AnneNoel
-
依托单位:
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.82万
-
财政年份:2010
-
负责人:Samaha, AnneNoel
-
依托单位:
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.82万
-
财政年份:2009
-
负责人:Samaha, AnneNoel
-
依托单位:
Equipment for assessing the effects of chronic dopamine receptor blockade on reward
-
批准号:376185-2009
-
项目类别:Research Tools and Instruments - Category 1 (<$150,000)
-
资助金额:$2.58万
-
财政年份:2008
-
负责人:Samaha, AnneNoel
-
依托单位:
Dopamine supersensitivity following chronic anti-dopaminergic treatment
-
批准号:355923-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.82万
-
财政年份:2008
-
负责人:Samaha, AnneNoel
-
依托单位:
海外基金